Company intelligence / Profile preview

Beecham Pharmaceuticals

Brentford, United Kingdom

Ownership: Private
Development stage: Other

Overview

Beecham Pharmaceuticals was a prominent British pharmaceutical company known for its pioneering work in antibiotics and consumer healthcare. Founded as a family business in the 19th century, it became a global leader after developing the first semi-synthetic penicillins in the 1950s and 1960s. The company was responsible for blockbuster drugs such as Amoxil (amoxicillin) and Augmentin. In 1989, Beecham merged with SmithKline Beckman to form SmithKline Beecham, which later merged with Glaxo Wellcome in 2000 to create GSK. The legacy of Beecham continues today through GSK's extensive portfolio of anti-infectives and mental health treatments.

Therapeutic areas: PsychiatryImmunologyRheumatologyInfectious Diseases
Modalities: Small moleculeVaccine
Industry: Pharma

Partnerships

SmithKline Beckman

Beyond the preview

Go deeper on Beecham Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beecham Pharmaceuticals.

Explore the full profile